Bioinfogate
Bioinfogate is a Barcelona-based life sciences analytics company that produces the OFF-X translational safety intelligence portal, now operating within Clarivate's Life Sciences & Healthcare division to serve pharmaceutical and biotechnology pharmacovigilance teams with integrated preclinical and clinical drug-safety data.
- Company typePrivate
- Founded2016
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Bioinfogate does
Bioinfogate is a Barcelona-based life sciences analytics company founded in 2016 that develops and operates the OFF-X translational safety intelligence portal. The company was co-founded by Josep Prous and now operates within Clarivate's Life Sciences & Healthcare division, which is headquartered in Philadelphia and serves more than 3,000 life sciences organizations globally. Bioinfogate employs between 11 and 50 people and is positioned as a specialized analytics provider within a much larger parent portfolio.
OFF-X is Bioinfogate's core product and delivers unique insights into drug and class toxicity by integrating preclinical and clinical safety data into a translational intelligence layer used by pharmaceutical and biotechnology pharmacovigilance teams. The portal is differentiated by domain specialization in drug safety rather than by being a general-purpose literature database, and it sits alongside Clarivate's broader portfolio of AI-powered intelligence platforms — including the Cortellis suite (Competitive, Deals, Drug Discovery, Clinical Trials, Regulatory, and CMC Intelligence), Drug Safety Triager, BioWorld, DRG Market Assessment, and Healthbase.
Revenue is generated through subscription-based SaaS contracts and professional services sold via an enterprise field sales motion with personalized demos, consulting engagements, and direct customer support across global pharma, biotech, and medtech accounts. Pricing is quote-based and not publicly disclosed. Customer testimonials from Menarini and Gedeon Richter illustrate use cases spanning patient-centricity initiatives and regulatory workflow transformation, validating the platform's positioning with top-tier pharmaceutical buyers. The combined business model is recurring-revenue anchored, with consulting and benchmarking services providing adjacent monetization on top of the subscription core.
Bioinfogate firmographics
Firmographics- Name
- Bioinfogate
- Website
- https://bioinfogate.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bioinfogate is a Barcelona-based life sciences analytics company that produces the OFF-X translational safety intelligence portal, now operating within Clarivate's Life Sciences & Healthcare division to serve pharmaceutical and biotechnology pharmacovigilance teams with integrated preclinical and clinical drug-safety data.
- Ownership category
- akta.pro rank
Bioinfogate industry classification
Industry- Product category
- Drug Safety Intelligence
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- akta.pro primary industry
- Translational Medicine & Biomarkers (HLAIALAF)
- akta.pro secondary industries
- Signal Detection & Safety Analytics (Epidemiology/RWE) (HLAGALAC), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where Bioinfogate is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Bioinfogate business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Subscription-based SaaS Platforms: Subscription-based access to intelligence platforms including Cortellis, DRG, BioWorld and other analytics tools. Revenue generated through annual or multi-year subscription contracts with life sciences organizations.
- Professional Services: Highly experienced team of expert consultants providing integrated research, data, and analytics services. Includes commercial consulting, R&D consulting, technology consulting, and benchmarking services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Bioinfogate product offering
Product offeringCore offering
Bioinfogate produces the OFF-X portal, a translational safety intelligence platform that delivers integrated preclinical and clinical data insights into drug and class toxicity. The platform supports life sciences organizations in assessing and managing drug safety profiles across the development lifecycle.
Product overview
No Bioinfogate product information available in the provided sources. The source data contains information about Clarivate's Life Sciences & Healthcare offerings, which includes products such as Cortellis (Competitive Intelligence, Deals Intelligence, Drug Discovery Intelligence, Clinical Trials Intelligence, Regulatory Intelligence, Product Intelligence), DRG (Market Assessment, Epidemiology Intelligence), BioWorld, OFF-X Translational Safety Intelligence, Drug Safety Triager, Dialog, Healthbase, MetaCore, and various consulting services. However, these products belong to Clarivate, not Bioinfogate.
Differentiator
Problem solved
Functional benefit
Products and services
- OFF-X Translational Safety Intelligence Translational safety intelligence platform produced by Bioinfogate that delivers unique insights into drug and class toxicity using integrated preclinical and clinical data. It is intended for life sciences organizations (pharmaceutical and biotechnology companies) that need to assess translational safety across the drug development lifecycle and support pharmacovigilance and drug safety workflows.
Companies that use Bioinfogate
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles1 record
Bioinfogate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Bioinfogate partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered notable.
- MenarininotableMenarini, a pharmaceutical company, works with Clarivate for patient-centricity initiatives. Regional Medical Affairs Director Dr. Ankur Gupta provides testimonial praising Clarivate's novel approaches and extensive research.
- Gedeon RichternotableGedeon Richter partnered with Clarivate consultants to transform regulatory workflow. Regulatory Intelligence Expert Kinga Pallay notes improved regulatory alert management and newsletter distribution.
Scale indicators5 records
Recent moves5 records
Expansion highlights4 records
Bioinfogate competitors and assessment
Company assessmentDirect peers
- ArisGlobal: ArisGlobal offers LifeSphere Safety, a leading pharmacovigilance and drug safety platform used by life sciences companies. Directly comparable to Bioinfogate's OFF-X because both target pharma safety teams with software-driven signal detection and case-management workflows.
- Citeline (Informa Pharma Intelligence): Citeline/Informa Pharma Intelligence provides pharma pipeline, trial, and competitive intelligence across the drug lifecycle. Comparable to Bioinfogate's analytics positioning given the parallel use of AI/ML-driven intelligence for pharma R&D and portfolio decisions.
- Veeva Systems (Vault Safety): Veeva Vault Safety is a cloud-native pharmacovigilance and drug safety suite used across large pharma. Comparable to Bioinfogate in serving regulated safety workflows with subscription-based SaaS delivery to enterprise life sciences customers.
- Evaluate (formerly Evaluate Pharma): Evaluate provides commercial and R&D intelligence, including safety/regulatory data, used by pharma for portfolio and deal-making decisions. Comparable to Bioinfogate OFF-X and the broader Cortellis-class intelligence offering in target customers and subscription SaaS model.
- Elsevier PharmaPendium: PharmaPendium is a regulatory and drug safety intelligence database covering preclinical, clinical, and post-marketing safety data. Directly comparable to OFF-X in addressing translational and regulatory safety questions for pharma and biotech.
- Oracle Health Sciences (Argus Safety): Oracle's Argus Safety and Empirica are enterprise pharmacovigilance and safety signal-detection platforms widely deployed at top-30 pharma. Overlaps with Bioinfogate OFF-X on safety analytics and translational safety use cases for large life sciences customers.
Emerging players
- GlobalData Healthcare: GlobalData Healthcare offers pharma intelligence, including drug safety, clinical trials, and competitive data. Comparable to Bioinfogate OFF-X in subscription data/analytics delivery to life sciences commercial and R&D teams, though with a broader rather than safety-focused scope.
- Adverse Events (Advera Health / part of Illuminate): Advera Health provides drug safety analytics and signal detection on adverse event data for pharma, payers, and providers. Highly comparable to OFF-X on translational/pharmacovigilance safety analytics for life sciences organizations.
Broad incumbents
- IQVIA: IQVIA is a broad life sciences data, analytics, and services incumbent offering safety, regulatory, and real-world evidence solutions. Comparable to Bioinfogate in addressing safety analytics for top pharma, though as part of a much larger portfolio rather than a focused translational safety platform.
Others
- BioReliance (MilliporeSigma): BioReliance provides preclinical and biopharma testing services, including safety/virology assessments. Related rather than directly comparable: Bioinfogate is a safety intelligence software provider while BioReliance is a wet-lab testing services provider—comparable on the safety data domain but different in delivery model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Bioinfogate social profiles
Digital presenceBioinfogate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioinfogate leadership team
Management profileNumber of profiles
Profiles1 record
Bioinfogate funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioinfogate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioinfogate
What does Bioinfogate do?
Bioinfogate produces the OFF-X portal, a translational safety intelligence platform that delivers integrated preclinical and clinical data insights into drug and class toxicity. The platform supports life sciences organizations in assessing and managing drug safety profiles across the development lifecycle.
Is Bioinfogate a public or private company?
Bioinfogate is a private company. It is classified as unknown and is currently operating.
When was Bioinfogate founded?
Bioinfogate was founded in 2016. It employs 11 to 50 people.
Where is Bioinfogate based?
Bioinfogate is headquartered in Barcelona, Spain, in the Europe region.
How does Bioinfogate make money?
Two revenue lines are on record. Subscription-based SaaS Platforms are the primary driver. The others are professional Services.
Who are Bioinfogate's main competitors?
Direct peers on record are ArisGlobal, Citeline (Informa Pharma Intelligence), Veeva Systems (Vault Safety), Evaluate (formerly Evaluate Pharma), Elsevier PharmaPendium and Oracle Health Sciences (Argus Safety). Emerging players are GlobalData Healthcare and Adverse Events (Advera Health / part of Illuminate). IQVIA is listed as a broad incumbent. BioReliance (MilliporeSigma) is listed as an others.
Does Bioinfogate have an API?
No public API is recorded for Bioinfogate.
What industry is Bioinfogate in?
Bioinfogate's product category is Drug Safety Intelligence. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAGALAC, Signal Detection & Safety Analytics (Epidemiology/RWE). Its NAICS code is 541714.